Laurion Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24,700
Closed -$7.72M 295
2024
Q2
$7.72M Sell
24,700
-75,500
-75% -$22.2M 0.09% 128
2024
Q1
$28.5M Sell
100,200
-362,200
-78% -$106M 0.24% 90
2023
Q4
$133M Buy
462,400
+461,600
+57,700% +$126M 1.13% 16
2023
Q3
$215K Buy
+800
New +$200K ﹤0.01% 426
2023
Q2
Sell
-250,000
Closed -$60.4M 599
2023
Q1
$60.4M Buy
+250,000
New +$61.4M 0.41% 59
2021
Q1
Sell
-39,900
Closed -$9.17M 738
2020
Q4
$9.17M Buy
+39,900
New +$9.2M 0.07% 195
2020
Q3
Sell
-14,900
Closed -$213K 823
2020
Q2
$213K Sell
14,900
-49,100
-77% -$11.2M ﹤0.01% 774
2020
Q1
$13M Buy
64,000
+40,500
+172% +$8.85M 0.14% 144
2019
Q4
$5.67M Hold
23,500
0.04% 292
2019
Q3
$4.55M Buy
+23,500
New +$4.51M 0.03% 355
2019
Q2
Sell
-40,000
Closed -$7.6M 882
2019
Q1
$7.6M Sell
40,000
-200
-0.5% -$38.2K 0.1% 157
2018
Q4
$7.83M Buy
40,200
+30,200
+302% +$5.89M 0.14% 197
2018
Q3
$2.07M Hold
10,000
0.02% 528
2018
Q2
$1.85M Sell
10,000
-181,100
-95% -$32M 0.01% 623
2018
Q1
$32.6M Sell
191,100
-7,500
-4% -$1.38M 0.26% 93
2017
Q4
$34.5M Sell
198,600
-73,000
-27% -$12.9M 0.18% 131
2017
Q3
$50.6M Buy
271,600
+174,100
+179% +$30.8M 0.22% 76
2017
Q2
$16.8M Buy
97,500
+26,500
+37% +$4.31M 0.09% 215
2017
Q1
$11.6M Buy
+71,000
New +$11.8M 0.09% 243
2016
Q4
Sell
-80,300
Closed -$13.4M 1092
2016
Q3
$13.4M Buy
80,300
+20,800
+35% +$3.52M 0.13% 176
2016
Q2
$9.05M Buy
+59,500
New +$9.25M 0.14% 174
2016
Q1
Sell
-100,000
Closed -$16.2M 774
2015
Q4
$16.2M Buy
+100,000
New +$15.7M 0.15% 147
2015
Q3
Sell
-100,000
Closed -$15.4M 726
2015
Q2
$15.4M Buy
+100,000
New +$16M 0.14% 178
2013
Q3
Sell
-48,300
Closed -$4.77M 176
2013
Q2
$4.77M Buy
+48,300
New +$5.01M 0.3% 75

Other funds holding AMGN

Laurion Capital Management's AMGN Position: Q1 2026 in Review

Laurion Capital Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 3,000 shares — an estimated $982K sold.

Laurion Capital Management first reported a position in AMGN in Q2 2013 and held it in 18 quarters. The position peaked at $19.7M in Q3 2014. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Laurion Capital Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Laurion Capital Management sold 3,000 Amgen shares in Q1 2026, an estimated $982K.
  • Laurion Capital Management first reported a position in Amgen in Q2 2013 and held it in 18 quarters.
  • Laurion Capital Management's Amgen position peaked at $19.7M in Q3 2014.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.